Updated: January 21, 2026
How to Save Money on Voydeya in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

Summarize with AI
- How Much Does Voydeya Cost Without Insurance?
- Option 1: Alexion OneSource Copay Program (Commercially Insured Patients)
- Option 2: Alexion Patient Assistance Program (Uninsured or Underinsured)
- Option 3: Fight Your Insurance Denial — Voydeya Is Often Covered After Appeal
- Option 4: Non-Profit and Foundation Assistance
- Option 5: Medicare and Medicaid Patients — Special Considerations
- What About GoodRx and Coupon Apps?
Voydeya can cost $50,000–$100,000 per year. Learn how to use the Alexion OneSource Copay Program, patient assistance, and appeals to reduce your out-of-pocket costs in 2026.
Voydeya (danicopan) is one of the most expensive oral medications currently on the market, with an annual cost of $50,000 to $100,000 for danicopan alone — on top of the ongoing cost of the C5 inhibitor (eculizumab or ravulizumab) it's paired with. If you have been prescribed Voydeya, it is critical to understand every financial resource available to you. This guide walks through all the ways to reduce your Voydeya costs in 2026.
How Much Does Voydeya Cost Without Insurance?
Without insurance, Voydeya's retail cost ranges from approximately $4,043 for a 180-tablet supply of the 50 mg/100 mg combination to $5,388 for 180 tablets of the 100 mg strength alone, based on published pricing data. A full year of treatment at the 150 mg TID dosing (180 tablets per month cycle) could run $50,000 to $100,000 depending on dose and packaging configuration. Since Voydeya is a brand-name-only drug with no generic available as of 2026, discount card programs like GoodRx do not apply through specialty pharmacy channels.
Option 1: Alexion OneSource Copay Program (Commercially Insured Patients)
The most powerful savings tool for commercially insured Voydeya patients is the Alexion OneSource Copay Program. Eligible patients can have their out-of-pocket costs reduced to as little as $0 per prescription, with a maximum savings limit of $15,000 per calendar year.
Eligibility: Commercially insured patients only (does NOT apply to Medicare, Medicaid, TRICARE, or other government insurance)
Maximum savings: Up to $15,000 per calendar year
How to enroll: Call 1-888-765-4747 or visit alexiononesource.com. You can also submit the enrollment form by fax to 1-800-420-5150.
Duration: No listed expiration date; reauthorization is annual in line with your PA renewal
Option 2: Alexion Patient Assistance Program (Uninsured or Underinsured)
If you do not have insurance or your insurance has denied coverage for Voydeya, Alexion Pharmaceuticals offers a patient assistance program (PAP) for qualifying patients. Eligibility requirements — including income thresholds — vary by program. Contact Alexion OneSource directly at 1-888-765-4747 to find out if you qualify and to start the application process.
Option 3: Fight Your Insurance Denial — Voydeya Is Often Covered After Appeal
Many Voydeya prescriptions are denied on first submission. This is common with specialty drugs that cost over $50,000 per year. Do not accept a denial as the final word. Steps to take:
Ask your hematologist to request a peer-to-peer review with your insurer's medical director. This is a call between your doctor and the insurance company's physician reviewer.
File a formal internal appeal within the timeframe specified in your denial letter (usually 30–180 days, depending on your plan).
If the internal appeal fails, request an independent external review. In many states, external appeals for rare disease specialty medications have success rates of 50–72%.
Option 4: Non-Profit and Foundation Assistance
Several non-profit organizations provide financial assistance to PNH patients, which can help cover copays, travel costs, and related expenses:
HealthWell Foundation — offers disease-specific copay assistance funds for rare blood disorders
Patient Advocate Foundation — provides case management and financial support for patients with chronic, life-threatening conditions
AA&MDS International Foundation — aplastic anemia and MDS foundation with resources for PNH patients
NeedyMeds.org — database of patient assistance programs and disease-specific foundations
Option 5: Medicare and Medicaid Patients — Special Considerations
If you have Medicare or Medicaid, you cannot use Alexion's commercial copay assistance program due to federal anti-kickback regulations. However, you may still have access to:
Medicare Low Income Subsidy (Extra Help) program for Medicare Part D drug costs
Alexion's independent patient assistance program for uninsured/low-income patients (contact OneSource for details)
Non-profit foundations listed above, which are not subject to the same federal restrictions as manufacturer programs
What About GoodRx and Coupon Apps?
Standard coupon apps like GoodRx, SingleCare, and RxSaver do not work for Voydeya because it is only dispensed through Onco360 specialty pharmacy — not through retail pharmacies where discount cards apply. The Alexion OneSource Copay Program is a much more powerful savings tool for Voydeya, offering up to $15,000 in annual savings for eligible commercially insured patients.
Need help navigating Voydeya access and cost? medfinder can help you locate your specialty pharmacy and understand your options. Also see our guide on how to find Voydeya in stock near you.
Frequently Asked Questions
Without insurance, Voydeya (danicopan) costs approximately $4,000–$5,400 per 180 tablets (roughly a month's supply), or $50,000–$100,000 per year. With commercial insurance and the Alexion OneSource Copay Program, out-of-pocket costs can be reduced to as low as $0 per prescription for eligible patients, with up to $15,000 in annual savings.
The Alexion OneSource Copay Program functions as Voydeya's savings card for commercially insured patients. It can reduce out-of-pocket costs to $0 per prescription with up to $15,000 in annual savings. Enroll by calling 1-888-765-4747 or visiting alexiononesource.com. Standard coupon cards (GoodRx, SingleCare) do not apply because Voydeya is only available through specialty pharmacy.
Medicare and Medicaid patients cannot use Alexion's commercial copay assistance program due to federal regulations. However, Medicare Part D covers Voydeya, and patients may qualify for Medicare's Extra Help (Low Income Subsidy) program. Non-profit organizations like the HealthWell Foundation and Patient Advocate Foundation may also provide assistance regardless of insurance type.
If the copay program doesn't cover your costs, contact Alexion OneSource (1-888-765-4747) about the patient assistance program for uninsured or low-income patients. Non-profit foundations such as the HealthWell Foundation or AA&MDS International Foundation may also provide grants. If your insurance denied coverage, file an appeal — many patients succeed at the external appeal level.
No. As of 2026, Voydeya (danicopan) is a brand-name-only drug with no generic available. Given its March 2024 approval date and patent protection, a generic is not expected in the near future. The Alexion OneSource Copay Program is currently the most effective tool to reduce out-of-pocket costs for commercially insured patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Voydeya also looked for:
More about Voydeya
30,239 have already found their meds with Medfinder.
Start your search today.





